Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
North America Diabetic Socks Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Type (Calf Length, Knee Length and Ankle Length), By Country and Growth Forecast, 2023 - 2029
... The North America Diabetic Socks Market would witness market growth of 5.2% CAGR during the forecast period (2023-2029). Diabetic socks are made to promote blood flow, decrease the incidence of foot injuries, and keep the ... Read More
-
North America Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Country and Growth Forecast, 2023 - 2029
... 2029 The North America Disease Management Apps Market would witness market growth of 10.9% CAGR during the forecast period (2023-2029). IoT-connected disease management applications, such as wearables like fitness bands as well as wirelessly connected ... Read More
-
Global Diabetic Socks Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Type (Calf Length, Knee Length and Ankle Length), By Regional Outlook and Forecast, 2023 - 2029
... Global Diabetic Socks Market size is expected to reach $463.9 Million by 2029, rising at a market growth of 5.8% CAGR during the forecast period. With preventative care procedures, people with diabetes can effectively control ... Read More
-
Europe Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Country and Growth Forecast, 2023 - 2029
... The Europe Disease Management Apps Market would witness market growth of 11.8% CAGR during the forecast period (2023-2029). Healthcare practitioners need access to a variety of clinical resources. Doctors, nurses, and others with a need ... Read More
-
Europe Diabetic Socks Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Type (Calf Length, Knee Length and Ankle Length), By Country and Growth Forecast, 2023 - 2029
... Europe Diabetic Socks Market would witness market growth of 5.5% CAGR during the forecast period (2023-2029). Many firms have entered the market with a unique product offering to draw in many clients, spurred on by ... Read More
-
Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Trends Analysis Report By Application (C.difficle, Crohns Disease, IBS, Diabetes), By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global live biotherapeutic products and microbiome CDMO market size is expected to reach USD 358.07 million by 2030, registering a CAGR of 41.3% over the forecast period, according to a new ... Read More
-
Middle East And Africa Insulin Patch Pump Market 2023-2030
... forecast years from 2023 to 2030. Turkey, South Africa, Saudi Arabia, the United Arab Emirates, Egypt, and Rest of Middle East & Africa are analyzed in the market in this region. According to World Bank ... Read More
-
North America Insulin Patch Pump Market 2023-2030
... to 2030. Canada and the United States are analyzed in the market in this region. The rising prevalence of diabetes among Americans has driven the demand for insulin patch pumps. Moreover, the adoption of smart ... Read More
-
Asia-pacific Insulin Patch Pump Market 2023-2030
... in Japan, China, Australia & New Zealand, India, South Korea, ASEAN Countries, and Rest of Asia-Pacific. China accounts for one-fourth of the world’s diabetic population, according to data from the International Diabetes Federation. The demand ... Read More
-
Global Insulin Patch Pump Market 2023-2030
... a projected CAGR of 10.54% between 2023 and 2030. The rising diabetes prevalence across the globe, growing awareness of insulin patch pumps, and the integration of advanced technologies have driven the growth of the studied ... Read More
-
Europe Insulin Patch Pump Market 2023-2030
... 2030. Poland, Spain, the United Kingdom, Germany, France, Italy, and Rest of Europe are scrutinized in this region’s market. According to the World Bank’s estimates, in 2021, the diabetes prevalence in Poland was 6.8% for ... Read More
-
Latin America Insulin Patch Pump Market 2023-2030
... from 2023 to 2030. Brazil, Mexico, and Rest of Latin America are evaluated in the market report on this region. The high incidence of diabetes mellitus in Latin America has driven the insulin patch pump ... Read More
-
2023 Global: Diabetic Foot Ulcer Treatment - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetes Care Devices Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetic Retinopathy Treatment Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetic Nephropathy - Innovative Markets Forecast (2029) report
... 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in ... Read More
-
2023 Global: Digital Diabetes Management Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
2023 Global: Diabetes Therapeutics - Innovative Markets Forecast (2029) report
... 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in ... Read More
-
2023 Global: Diabetic Macular Edema - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
New Zealand Insulin Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)���
... of more than 4%. After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was in young pediatric and older adult patients with COVID-19. Type 1 diabetic patients were more ... Read More
-
United States Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... forecast period. Diabetic patients were at a higher risk of hospitalizations and complications during the COVID-19 pandemic due to hyper- or hypoglycemia, metabolic comorbidities, and a more severe SARS-CoV-2 infection.The maintenance of euglycemia was important ... Read More
-
New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, a diabetic patient will likely develop a serious illness and may even pass away. Diabetes ... Read More
-
United Kingdom Self-Monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... CAGR of more than 4.8%. The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair. According to Diabetes UK, in ... Read More
-
New Zealand Self-Monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... more than 5.2%. The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair.All the steps needed to protect this high-risk ... Read More
-
New Zealand Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients with COVID-19 had the highest risk. Patients with type 1 diabetes were more likely to ... Read More
Research Assistance
